Purpose
This document provides a clear, scientifically grounded explanation regarding concerns about potential benzene formation in products containing ascorbic acid (vitamin C) and sodium benzoate. It is intended for internal reference, customer support, and public-facing communication.
Background
Under certain stress conditions—such as elevated heat, prolonged light exposure, and the presence of trace transition metals—ascorbic acid and sodium benzoate can theoretically interact to form very small amounts of benzene. This phenomenon has been studied extensively by regulatory authorities, including the U.S. Food and Drug Administration (FDA).
Importantly, this reaction is not automatic and requires a combination of contributing factors that are actively controlled in modern formulations.
Formulation Controls and Safeguards
Our product design incorporates multiple layers of control to prevent the conditions associated with benzene formation:
Low levels of sodium benzoate within accepted regulatory limits
Controlled pH environment
Use of purified and low-metal-content inputs
Manufacturing under controlled conditions
Inclusion of antioxidant support within the formulation, including glutathione
These combined factors significantly reduce or eliminate the likelihood of benzene formation.
Analytical Testing
Third-party analytical testing has been conducted on the product. Under the conditions evaluated, benzene was not detected. While all analytical methods have defined sensitivity limits, these findings are consistent with expected outcomes for properly formulated products of this type. As with all analytical testing, results depend on the sensitivity of the method used. However, even under conservative, worst-case theoretical assumptions, any potential benzene formation would be expected to remain well below recognized safety limits.
Regulatory Context
Regulatory agencies have established safety thresholds for benzene exposure (e.g., 5 parts per billion in drinking water). Industry and regulatory data consistently show that properly formulated beverages containing ascorbic acid and sodium benzoate either contain no detectable benzene or levels far below these safety thresholds.
Conclusion
Based on formulation design, manufacturing controls, and third-party analytical testing, there is no evidence to suggest that benzene formation presents a safety concern in this product. The product aligns with industry best practices and regulatory expectations for safety and quality.
Comments
0 comments
Article is closed for comments.